...
首页> 外文期刊>Leukemia and lymphoma >Primary central nervous system lymphoma: the challenge continues.
【24h】

Primary central nervous system lymphoma: the challenge continues.

机译:原发性中枢神经系统淋巴瘤:挑战仍在继续。

获取原文
获取原文并翻译 | 示例
           

摘要

Clinicians managing primary central nervous system lym-phoma (PCNSL) face challenges in two distinct areas. The first is the disease itself. PCNSL is an aggressive malignancy for which current therapies have limited long-term success, and for which treatment intensification can often lead to unacceptable toxicity. The second challenge is the knowledge base informing the management of this condition, which rests largely on phase II trials and retrospective studies, with a paucity of prospective randomized trial data. Thus, key questions regarding optimal management remain unresolved.
机译:管理原发性中枢神经系统淋巴瘤(PCNSL)的临床医生在两个不同领域面临挑战。首先是疾病本身。 PCNSL是一种侵袭性恶性肿瘤,当前的治疗方法长期无法获得成功,其强化治疗常常会导致不可接受的毒性。第二个挑战是告知管理该病的知识库,该知识库主要取决于II期试验和回顾性研究,缺乏前瞻性随机试验数据。因此,关于最佳管理的关键问题仍未解决。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号